PROCEPT BioRobotics (PRCT) News
NASDAQ: PRCTHealth CareMedical/Dental InstrumentsUSD
18.40+0.50 (+2.79%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 18.50 +0.54%
PRCT news summary
We found 2 recent headlines mentioning PROCEPT BioRobotics (PRCT): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, PRCT is up 2.79% at $18.40. The most recent story, "Barclays Initiates Coverage of PROCEPT BioRobotics with Overweight Rating", was published by Nasdaq on Oct 7, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest PROCEPT BioRobotics headlines
- Barclays Initiates Coverage of PROCEPT BioRobotics with Overweight RatingFintel reports that on October 7, 2026, Barclays initiated coverage of PROCEPT BioRobotics (NASDAQGM:PRCT) (BMV:PRCT) with a Overweight recommendation.Prior to this rating action, the stock closed at…NasdaqPRCT, BCS
- Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.Key PointsJ&J's portfolio primarily includes small biotech and medtech companies.NasdaqPTGX, JNJ, LAB, XNCR